Achim Leo Burger
Overview
Explore the profile of Achim Leo Burger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burger A, Wegberger C, Tscharre M, Kaufmann C, Muthspiel M, Pogran E, et al.
Sports Med Open
. 2024 Jun;
10(1):67.
PMID: 38851665
Background: Participation in ultra-endurance races may lead to a transient decline in cardiac function and increased cardiovascular biomarkers. This study aims to assess alterations in biventricular function immediately and five...
2.
Kaufmann C, Muthspiel M, Lunzer L, Pogran E, Zweiker D, Burger A, et al.
J Clin Med
. 2024 Apr;
13(8).
PMID: 38673585
Acute coronary syndrome (ACS) remains a major challenge in clinical practice, requiring rapid and effective antithrombotic treatment to mitigate adverse ischemic events while minimizing the risk of bleeding. In recent...
3.
Pogran E, Burger A, Zweiker D, Kaufmann C, Muthspiel M, Rega-Kaun G, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610808
Achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets remains a significant challenge in clinical practice. This review assesses the barriers to reaching LDL-C goals and explores the potential solutions to these...
4.
Burger A, Hauser J, Kaider A, Stojkovic S, Diedrich A, Michel-Behnke I, et al.
Clin Chim Acta
. 2024 Mar;
557:117883.
PMID: 38521162
Introduction: Growth differentiation factor 8 (GDF-8, myostatin) has been proposed for the management of adult heart failure (HF). Its potential role in pediatric HF patients is unknown. We sought to...
5.
Burger A, Beran N, Pogran E, Kaufmann C, Zweiker D, Muthspiel M, et al.
Wien Klin Wochenschr
. 2023 Oct;
135(23-24):674-679.
PMID: 37874347
Background: Current guidelines recommend a stepwise initiation of lipid-lowering therapy after percutaneous coronary interventions (PCI) in treatment-naïve individuals. Patients might benefit from an earlier and stronger low-density lipoprotein-cholesterol (LDL-C) reduction...
6.
Kaufmann C, Ahmed A, Muthspiel M, Rostocki I, Pogran E, Zweiker D, et al.
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769623
Background: Excess cardiovascular (CV) morbidity and mortality has been observed in patients with COVID-19. Both interleukin-32 (IL-32) and interleukin-34 (IL-34) have been hypothesized to contribute to CV involvement in COVID-19....
7.
Burger A, Roesler C, Ebner J, Sommer P, Mutzenbach S, Winkler W, et al.
Eur J Neurol
. 2023 Feb;
30(7):2092-2098.
PMID: 36760043
Background And Purpose: Previous studies investigating prolonged electrocardiogram (ECG)-monitoring after ischemic stroke had significant gaps between the index event and the beginning of long-term monitoring. Atrial fibrillation (AF) detection might...
8.
Muthspiel M, Kaufmann C, Burger A, Panzer B, Verheugt F, Huber K
Front Cardiovasc Med
. 2022 Nov;
9:1008194.
PMID: 36440022
Dual antiplatelet therapy (DAPT) for 6-12 months, followed by lifelong aspirin monotherapy is considered an effective standard therapy for the prevention of thrombo-ischemic events in patients with acute and chronic...
9.
Maleczek M, Schebesta K, Hamp T, Burger A, Pezawas T, Krammel M, et al.
Scand J Trauma Resusc Emerg Med
. 2022 Jul;
30(1):47.
PMID: 35841049
Aims: Due to time-critical decision-making, physical strain and the uncontrolled environment, prehospital emergency management is frequently associated with high levels of stress in medical personnel. Stress has been known to...
10.
Burger A, Pogran E, Muthspiel M, Kaufmann C, Jager B, Huber K
Biomedicines
. 2022 May;
10(5).
PMID: 35625707
The effective and fast reduction of circulating low-density lipoprotein cholesterol (LDL-C) is a cornerstone for secondary prevention of atherosclerotic disease progression. Despite the substantial lipid-lowering effects of the established treatment...